Determination of celecoxib in human plasma using solid-phase extraction and high-performance liquid chromatography.

[1]  G. Koren,et al.  Single‐dose and steady‐state pharmacokinetics of celecoxib in children , 2002, Clinical pharmacology and therapeutics.

[2]  U. Hofmann,et al.  Simple and sensitive method for the determination of celecoxib in human serum by high-performance liquid chromatography with fluorescence detection. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  K. Brune,et al.  Investigation of the pharmacokinetics of celecoxib by liquid chromatography-mass spectrometry. , 2002, Biomedical chromatography : BMC.

[4]  G. Geisslinger,et al.  Determination of celecoxib in human plasma and rat microdialysis samples by liquid chromatography tandem mass spectrometry. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[5]  L. Novotný,et al.  Liquid chromatographic-mass spectrometric determination of celecoxib in plasma using single-ion monitoring and its use in clinical pharmacokinetics. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[6]  L. Tive.  Celecoxib clinical profile. , 2000, Rheumatology.

[7]  B. Levin,et al.  The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.

[8]  R. Bible,et al.  Metabolism and Excretion of [14C]Celecoxib in Healthy Male Volunteers , 2000 .

[9]  E. Woolf,et al.  Determination of celecoxib in human plasma by normal-phase high-performance liquid chromatography with column switching and ultraviolet absorbance detection. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[10]  J. Masferrer,et al.  Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy. , 1999, Expert opinion on investigational drugs.